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Transjugular intrahepatic portosystemic shunt 
(TIPS) is an artificial channel within the liver that 
establishes communication between the inflow portal 
vein and the outflow hepatic vein. It is used to treat 
portal hypertension complications like esophageal 
varices bleeding or ascites. TIPS indication has be-
come more frequent mainly in groups that perform 
liver transplants because it has been indicated as a 
bridge for liver transplantation.
In the paper published in this issue of ARQUIVOS 
de GASTROENTEROLOGIA(1), a high incidence 
of technical complications was observed. This series 
shows an initial experience, started many years ago 
charactering different expertises and devices, during 
the period here analyzed. Nowadays technical com-
plications like cervical hematoma, pneumothorax and 
hemothorax could be avoided with the use of ultra-
sound guidance to perform the transjugular approach. 
This may be result of the learning curve associated to 
the group performing TIPS.
Although major complications can occur during 
or as a result of  TIPS creation, they are generally 
uncommon and are reduced with increased operator 
experience.
Published rates for individual types of complica-
tions are highly dependent on patient selection and 
are based on series comprising several hundred pa-
tients, which is a volume larger than most individual 
practitioners are likely to treat. The overall procedure 
threshold is more appropriate for use in a QI program. 
Major complications occur in 5% of patients.
Concerning stent fracture with migration to the 
pulmonary artery, to the right ventricle and to the 
right atrium more experience in the stent deployment 
and the use of e-PTFE–covered stents is associated 
with reduction in the incidence of TIPS dysfunction 
and recurrence of complications.
Another issue is the efficacy of  e-PTFE–covered 
TIPS in controlling bleeding and thus preventing 
further clinical deterioration. The FDA has approved 
the e-PTFE–covered stent for TIPS and its indication 
has been proved by many authors to reduce variceal 
rebleeding and TIPS stenosis/dysfunction rates than 
bare stents. In addition, the use of  e-PTFE–covered 
stent is less expensive due to the less need for re-
interventions to treat stenosis and thrombosis of 
the shunts(2).
TIPS has been associated with encephalopathy 
episodes. But, in a recent publication, the early use of 
TIPS was not associated with an increase in the num-
ber or severity of episodes of hepatic encephalopathy. 
The study was specifically designed to show whether 
an early decision to use TIP S, and based on clinical 
criteria, could improve the prognosis for patients with 
variceal bleeding who were at high risk. It was found 
that in patients treated early with e-PTFE–covered 
stents TIPS, the risks of failure to control bleeding and 
of variceal rebleeding were reduced. This may result of 
clinical evaluation and indication before TIPS. Previous 
studies evaluating the role of TIPS in the prevention 
of  recurrent variceal bleeding clearly showed that 
TIPS reduces the rebleeding rate but increases hepatic 
encephalopathy without improving survival.
Recently, the decision to perform TIPS has been 
done based on the measurement of  hepatic venous 
pressure gradients, a test that is not widely available 
in many institutions, especially under emergency 
conditions.
Recent studies have shown that TIPS should 
not be used as the initial treatment in patients with 
Child–Pugh class A disease, since the rates of medical 
treatment failure and mortality are low among such 
patients. Although the risks of treatment failure and 
death can be higher in patients with Child–Pugh class 
C disease than in those with class B disease. Further-
more, in patients with Child–Pugh class C disease 
or class B disease with active bleeding who were 
admitted for acute variceal bleeding, the early use of 
TIPS with an e-PTFE–covered stent was associated 
with significant reductions in the failure to control 
-bleeding, in rebleeding, and in mortality, with no 
increase in the risk of hepatic encephalopathy(3).
Although the TIPS clinical indication it is now 
well established in the portal hypertension treatment 
it is always recommended to have a multidisciplinary 
approach to establish the right patient and moment 
to proceed with before liver transplantation.
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